• Nenhum resultado encontrado

Rev. Bras. Hematol. Hemoter. vol.37 número3

N/A
N/A
Protected

Academic year: 2018

Share "Rev. Bras. Hematol. Hemoter. vol.37 número3"

Copied!
4
0
0

Texto

(1)

rev bras hematol hemoter. 2015;37(3):207–210

w w w . r b h h . o r g

Revista

Brasileira

de

Hematologia

e

Hemoterapia

Brazilian

Journal

of

Hematology

and

Hemotherapy

Case

Report

Central

retinal

vein

occlusion

as

first

manifestation

of

relapse

in

acute

lymphoblastic

leukemia

Flávia

Kessler

Borges,

Júlia

Biegelmeyer,

Samantha

Thifani

Alrutz

Barcelos

,

Raquel

Cristine

Breunig

UniversidadeFederaldeCiênciasdaSaúdedePortoAlegre(UFCSPA),PortoAlegre,RS,Brazil

a

r

t

i

c

l

e

i

n

f

o

Articlehistory:

Received6November2014 Accepted31December2014 Availableonline14April2015

Introduction

Retinal vein occlusion is the second most common cause ofvisualloss dueto retinalvascular disease afterdiabetic retinopathy.1 Among the risk factors described, it is well knownthatthehypercoagulablestatepresentinneoplasias canculminateinveinocclusion.Itisdescribedthatanyocular structuremay beinvolvedinacuteleukemia2; involvement of the choroid and retina is the most common. However, leukemic cells can infiltrate the conjunctiva and lacrimal glands,producingobviousmasses.Kareshetal.publisheda twoyearprospectivestudy ofnewly diagnosedadultswith acutemyeloidleukemia;64%ofpatientshadretinaloroptic nerve abnormalities where hemorrhages and cotton wool spots(aconsequenceofnervefiberischemia)werethemost frequentfindings.3 Theassociation betweencentral retinal vein occlusion and acute lymphoblastic leukemia (ALL) relapsehasrarelybeendescribedthough.4–6Weherebyreport

Correspondingauthorat:RuaSarmentoLeite,245,Centro,90050-170PortoAlegre,RS,Brazil.

E-mailaddress:samanthatifani@gmail.com(S.T.A.Barcelos).

a case of central retinal vein occlusion as the presenting manifestationofrelapseinALL.

Case

report

A59-year-oldfemalewasdiagnosedwithALLinNovember 2013.Atthattime,shehadthefollowinglaboratoryresults: hemoglobin:8.7g/dL;redbloodcells:2.95×109/␮L;MCV:89fL; total leukocytes: 18.66×109/L; lymphocytes: 5.374×109/L;

segmented neutrophils: 2.930×109/L; blasts: 9143cells/␮L; uric acid: 5.2mg/dL; lactic dehydrogenase: 1672U/L; creati-nine: 3.1mg/dL; and urea: 83mg/dL. She received volemic resuscitation for tumor lysis syndrome. Subsequently, she developed pneumonia caused by Cryptococcus neoformans and herpeszoster skin lesions.Treatment was made with meropenem, amphotericin and acyclovir. In January 2014, aftercompletingtreatmentfortheinfections,shewas sub-mitted to chemotherapy induction using the hyperCVAD

http://dx.doi.org/10.1016/j.bjhh.2015.03.008

(2)

208

revbrashematolhemoter.2015;37(3):207–210

Figure1–Fluoresceinangiographyshowingocclusionofcentralretinalvein.

regimen–courseA(cyclophosphamide,vincristine, doxoru-bicinand dexamethasone).Immunophenotypingperformed inFebruary2014showedremissionofthedisease.

In March 2014 she presented febrile neutropenia and typhlitis.Empirictreatmentwithcefepimewasstartedand the hyperCVAD regimen was interrupted. Blood cultures

identifiedEscherichia coliandKlebsiellapnemoniae. Treatment wascompletedonApril20th2014.

(3)

revbrashematolhemoter.2015;37(3):207–210

209

tocompletethefourthcycleoftherapyduetohematological toxicity(hemoglobin:9.0g/dL;redbloodcells:2.71×109/␮L; totalleukocytes:0.870×109/L;neutrophils:0.628×109/L;and

platelets:13×109/L).

In August 2014 she came to our hospital emergency departmentcomplainingofaheadacheoftheright sideof her head, sensitivity to light, nausea, vomiting and visual lossinthe right eyethathad started four dayspreviously. Theneurological exam showed no abnormality, except for the eye fundus examination, which revealed papilledema, intraretinal peripapillary and inframacular hemorrhage in the right eye.The left eye presented a pre-retinal hemor-rhage.

Laboratory exams did not reveal any abnormality. A coagulation panel showed platelets 154×109/L;

prothrom-bin time activity: 100%; international normalization ratio (INR): 1.00; and activated partial thromboplastin time: 36.6s.

Anuclearmagneticresonanceimage(MRI)wasmade,and theonlyabnormalitywasahypointenselesionevidencedin theT2sequenceintherighttemporalposteriorregion,which wasprobablyasequelaeofaprevioushemorrhagicinfarct.

Shewasthensubmittedtoafluoresceinangiographythat revealedocclusionofthecentralretinalvein(Figure1).

Inordertoexcludeanyinfectiousetiology,alumbar punc-turewasmade,withanormalopeningpressure(150cmH2O). Cerebrospinal fluid analysis evidenced low glucose lev-els (28mg/dL and 89mg/dL in blood); high protein levels (89mg/dL); cellularity 2520cells/␮L; 94% blasts; 5% mono-cytes;and redbloodcells:220cells/␮L.Culturesforfungus, bacteriaandcytomegalovirusantigenemiaandherpesvirus polymerasechainreaction(PCR)wereallnegative.

Shewasnottakinganydrugthatwouldpotentiallybe capa-bleofinducingretinalveinocclusion.

Inordertocompletetheevaluationofpossible intracere-bralveinthrombosis,thepatientwassubmittedtoavascular MRIthatrevealedthickeningoftherightopticnerveandoptic chiasmprotuberance.

Immunophenotypingoftheliquorhad predominanceof CD10,CD19,DC22,CD34,HLADRcells,suggestingBlineage ALL. Lymphoblasts were identified in the cytopathological examandbonemarrowcytologyconfirmedmedullar infiltra-tion.

Afterconfirming neurologicalrelapse ofALL,intrathecal chemotherapy was given with dexamethasone, cytarabine andmethotrexate.Shehadcompleteremissionofheadache, buthadnoimprovementofhervisualloss.

Amagneticresonanceangiographyofthecentralnervous system(CNS)wascarriedouttoexcludeotherpossible vas-cularthrombosis,butnoalterationwasfoundintheexam, exceptforinfiltrationoftherightopticnerve.

Shewas dischargedfrom hospitalaftertwo sessions of intrathecal chemotherapy, and continues outpatient treat-ment.

Discussion

Therearefewcasesreportedintheliteratureshowingocular nerveinfiltrationasanisolatedmanifestationofALLrelapse,

even thoughit is aconsequenceof CNSinvolvementwith severeprognosis.Inthecasereportedherein,thepatienthada headacheassociatedwithvisualloss,whichstronglysuggests CNS damage.Onceher ophthalmologic exam showedonly centralretinalveinocclusion(CRVO),theclinicaldiscussion focusedontheetiology oftheunderlyingprocess:whether it was aconsequenceofa hypercoagulablestateor dueto directinvasionofneoplasticcellssincebothconditionscan culminateinCRVO.

Inordertoelucidatethisquestion,amagneticresonance angiography wasperformed toexcludeother possiblevein occlusionsintheCNS,buttheonlyfindingwasopticnerve infiltration,whichhadnotbeenevidentuntilthismoment. IthasalreadybeendescribedthatMRIisusefulintheearly detectionofocularinvolvement.7

EventhoughCRVOisrelatedwithanhypercoagulablestate, allthecasesdescribedintheliteraturethatassociateCRVO withALLaresecondarytoaninfiltrationofleukemiccells.4–6 Allcasesshowinfiltrationoftheopticdiskprecedingvessel occlusion.

Treatmentdescribedinthesecasesconsistsinintrathecal chemotherapyandradiotherapy.8,9Thereisnobenefitin pre-scribingvascularendothelialgrowthfactor(VEGF)inhibitors inthesecases,asthereiscombineddamageofthevein cir-culationandtheopticnerveconduction;thelattercancause irreversiblevisualloss.10

Conclusion

CNSrelapsecanprecedehematologicalsignsandsymptoms, and regular ophthalmologic exams should be instituted in patients withALL. If ocularsymptomsare presentand the ophthalmologicexamisnormal,aMRIshouldbeconsidered. In cases of ALL and retinal vessel occlusion, always con-sideropticnerveinfiltrationandrapidlyinstitutetreatment withintrathecalchemotherapyandradiotherapytoavoid irre-versibledamage.

Conflicts

of

interest

Theauthorsdeclarenoconflictsofinterest.

r

e

f

e

r

e

n

c

e

s

1.CugatiS,WangJJ,RochtchinaE,MitchellP.Ten-yearincidence

ofretinalveinocclusioninanolderpopulation:theBlue

MountainsEyeStudy.ArchOphthalmol.2006;124(5):726–32.

2.RosenthalAR.Ocularmanifestationsofleukemia.Areview.

Ophthalmology.1983;90(8):899.

3.KareshJW,GoldmanEJ,ReckK,KelmanSE,LeeEJ,Schiffer

CA.Aprospectiveophthalmicevaluationofpatientswith

acutemyeloidleukemia:correlationofocularand

hematologicfindings.JClinOncol.1989;7(10):1528.

4.SalazarMendezR,FonollaGilM.Unilateralopticdiskedema

withcentralretinalarteryandveinocclusionsasthe

presentingsignsofrelapseinacutelymphoblasticleukemia.

ArchSocEspOftalmol.2014;89(11):

(4)

210

revbrashematolhemoter.2015;37(3):207–210

5. ChanWM,LiuDT,LamDS.Imagesinhaematology.Combined

centralretinalarteryandveinocclusionsasthepresenting

signsofocularrelapseinacutelymphoblasticleukaemia.BrJ

Haematol.2005;128(2):134.

6. BadelonI,ChaineG,TolubO,CoscasG.Occlusionofthe

centralveinandarteryoftheretinacausedbyinfiltrationof

theopticnerveinlymphoblasticacuteleukemia.BullSoc

OphtalmolFr.1986;86(3):261–4.

7. DeFátimaSoaresM,BragaFT,daRochaAJ,LedermanHM.

Opticnerveinfiltrationbyacutelymphoblasticleukaemia:

MRIcontribution.PediatrRadiol.2005;35(8):799–802.

8.KaikovY.Opticnerveheadinfiltrationinacuteleukemia

inchildren:anindicationforemergencyopticnerve

headradiationtherapy.MedPediatrOncol.1996;26(2):

101–4.

9.MayoGL,CarterJE,McKinnonSJ.Bilateralopticdiskedema

andblindnessasinitialpresentationofacutelymphocytic

leukemia.AmJOphthalmol.2002;134(1):141–2.

10.BraithwaiteT,NanjiAA,GreenbergPB.Anti-vascular

endothelialgrowthfactorformacularedemasecondaryto

centralretinalveinocclusion.CochraneDatabaseSystRev.

Imagem

Figure 1 – Fluorescein angiography showing occlusion of central retinal vein.

Referências

Documentos relacionados

Objective: The aim of this study was to compare a fractionated dose of 15 ␮g G-CSF/kg of body weight and the conventional dose of granulocyte-colony stimulating factor in respect to

Concerning to the use of hydroxyurea, a significant dif- ference was observed in the levels of arginase I in patients who used lower doses (<20 mg/kg/day) compared to those on

Thus, this study aimed to characterize the demographic and socioeconomic aspects of SCD patients from the state of Rio Grande do Norte (RN), a socioeconomic vulnerable area

Objective: By applying receiver operating characteristic curve analysis, the objective of this study was to see whether hemoglobin levels reflect body iron stores in a group of

Conclusions: Hematopoietic cell transplantation for relapsed Hodgkin’s lymphoma is a potentially curative procedure especially in patients in complete remission at the time

Iron deficiency or impairment of iron availability is the most frequent cause of rHuEPO treatment resistance in patients under

The objective of this study was to characterize the hematological parame- ters, clinical features, and molecular basis of very mild forms of Hb S/ ␤ + -Thal in a newborn cohort of

An 18-year-old female patient (height 147 cm and weight 40 kg) belonging to the ‘Chasa’ caste was admitted to the Depart- ment of Medicine of Veer Surendra Sai Medical College